The Story Behind the Science A Conversation with Paul Stroili, Vice President of Creative by Ginger Claremohr, Claremohr Writing Co. A Life in Stories Long before he was helping shape the visual identity of Thalocan Research Innovations, Paul Stroili was telling stories from a stage. For more than four decades, he has worked as an…
Thalocan Research Innovations CEO Eric Zudak is heading to New York City, July 16–19, for The 2026 AAD Innovation Academy, a unique program packed with the latest breakthroughs in dermatology. The AAD Innovation Academy delivers cutting-edge clinical insights and meaningful networking moments. One breakthrough sure to be discussed is the enthusiastic response to our Lesion…
Today is World Vitiligo Day, a global campaign dedicated to raising awareness, ending social stigma, and advocating for people living with vitiligo. Originally launched in 2011, the day unites the international community to promote research and support for those affected. At Thalocan Research Innovations Research Innovtions, we applaud the work of the GLOBAL VITILIGO FOUNDATION…
Thalocan Research Innovations team members Eric Zudak, Teresa DeHaemer and Tyler White are looking forward to an exciting few days at the Revolutionizing Atopic Dermatitis Conference (RAD 2026) in Nashville. This 3-day conference will focus exclusively on AD and the complex information that has accrued around proper diagnosis, treatment, and management. Our TRI team will…
